Clinical observation of co-treatment with autologous CIK cells and dendritic cells for postoperative advanced gastric carcinoma

Chinese Journal of Clinical Oncology

Volumn 34, Issue 14, 2007, Pages 803-806

  Gong, Xinjian ^a   Liu, Junquan ^a   Li, Xi ^a  

^a 97th Hospital of PLA   (China)

Author keywords

Cellular immunotherapy; Cytokine induced killer (CIK) cells; Dendritic cells (DC); Gastric carcinoma

Indexed keywords

EID: 77951732360     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Schmitz M, Zhao S, Deuse Y, et al. Tumorcidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity [J]. J Immunol, 2005, 174(7): 4127-4134 (Pubitemid 40395990)
2. Jongmans W, Tiemessen DM, van Vlodrop IJ, et al. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails[J]. J Immunother, 2005, 28(5): 480-487 (Pubitemid 41232569)
3. Liu K, Caldwell SA, Greeneltch KM, et al. CTL adoptive immunotherapy concurrently mediates tumor regression and tumor escape[J]. J Immunol, 2006, 176(6): 3374-3382 (Pubitemid 43363984)
4. Dudley ME, Wunderlich JR., Yang JC, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma[J]. J Clin Oncol, 2005, 10(1): 2346-2357
5. Gattinoni L, Powell D, Rosenberg SA et al. Adoptive immunotherapy for cancer: building on success [J]. Nat Rev Immunol, 2006, 6(5): 383-393